Introduction
The habitat diversity in Egypt,
as a result of geographical, physiographic, edaphic and climatic conditions, is
reflected on the plant life. The remedies used by ancient Egyptian physicians
came mostly from nature, more especially medicinal herbs. Most of medicinal
modalities
originated from ancient Egyptian; one of them was herbal medicine. The famous
Ebers Papyrus, written in 1550 B.C., gives 842 prescriptions that are made of
328 different ingredients. Among them are plant species growing in Egypt or other
North African countries, e.g. Artemisia absinthium, Acacia spp. and
Balanites aegyptiaca. Nowadays; Medicinal plants are considered as
an important health and economic component of the flora in developed as well as
developing countries. Increasing world-wide interest in herbal remedies,
expanding reliance of local health care of traditional remedies and a renewed
interest in the development of pharmaceuticals from plant sources have greatly
increased trade in medicinal plant materials but it is
hindered by lack of technical and economic data. Important
populations of medicinal plants are found not only in the regions and
ecosystems with high biological diversity, but also in less diverse flora and
in floristic communities that are not a common focus of conservation efforts.
For instance, in the arid and semi-arid zones of the Middle East, the flora may
comprise very important genetic resources of crop and medicinal plants.
Conservation of threatened and endangered medicinal plant species in the wild
is indispensable. Egyptian Herbal Monograph is crucial because it represents
our nation's best chance at conserving our medicinal plants through the wise
use of our unique biodiversity resources in the pharmaceutical industry. In
addition to the conservation of such natural resources, the wild medicinal
plants that grow in Egyptian phytogeographical regions can be cultivated in new
reclaimed lands with the least harmful ecological impacts.
Since 2020, the Egyptian Drug
Authority (EDA) has been developing the Egyptian Herbal Monograph in
alignment with internationally recognized formats, including those of the
European Union, Canada, and the World Health Organization (WHO). In 2022, the
EDA compiled the initial three volumes into a single comprehensive document and
expanded it by adding a fourth volume on herbal formulations, issuing the first
complete version. This was followed by annual revisions, resulting in the
publication of the second and third version in 2023 and 2024, respectively. In
2025, the EDA is set to release the fourth version, which consolidates the
previously separate volumes on wild plants into a single unified volume and
introduces a newly added volume dedicated to “Aromatherapy”. The inclusion of
the Aromatherapy volume in the fourth version of the Egyptian Herbal
Monograph was driven by the increasing scientific and regulatory interest
in essential oils and their therapeutic applications. Aromatherapy, which
utilizes plant-derived essential oils for physical and psychological
well-being, has gained substantial global attention due to its integration into
both traditional and modern healthcare practices.
The Egyptian Herbal Monograph
serves as an authoritative reference for the scientific dossiers required in
the registration of herbal medicinal products.
Purpose
and content of the monograph
The
purpose of the monograph is to:
·
Provides
updated scientific information on the safety, efficacy and quality of the
Egyptian medicinal plants.
·
Facilitates
their appropriate use.
·
Facilitates
information exchange and registration procedures.
This
monograph was put together by a working group comprised of members of the
Specialized Scientific Committee of Herbal Medicines and the Egyptian Drug
Authority (EDA). It is a compilation of the medicinal plants used in Egypt that
offers comprehensive data including botanical, chemical and pharmacological
information that is properly organized.
The
Egyptian Monograph aims to encourage the appropriate use of herbal remedies
with the highest level of safety and efficacy based on previous and current
research. Each monograph follows a standard format with information and
followed by a reference list. Each monograph contains all the available
information and scientific results on the selected species include the following:
names, synonyms, parts used for medicinal purposes, major chemical
constituents, medicinal uses (indications), herbal preparations correlated to
the medicinal use, posology and method of administration correlated to
medicinal use, contraindications, special warnings and precautions for use,
interactions with other medicinal products, other forms of interaction, effects
on fertility, pregnancy, lactation, ability to drive, using machines,
undesirable effects, overdose, relevant biological activities and if any
additional information. This monograph is expected to go through another
revision soon in response to advances in the field of herbal medicine research.